Doctronic AI, the AI-native health platform delivering fast, private, and personalized healthcare at scale, today announced the appointment of Byron Crowe, MD, MSc as Chief Medical Officer (CMO). In this role, Dr. Crowe will lead Doctronic’s clinical strategy and product innovation efforts while expanding the company’s affiliated nationwide physician practice.
In addition to his industry leadership, Dr. Crowe is an accomplished academic clinician, most recently serving on the faculty at Harvard Medical School and as a practicing physician at Beth Israel Deaconess Medical Center. His research focused on evaluating large language model–based AI systems in complex diagnosis and clinical reasoning, and he has co-authored landmark studies and major society guidelines on the use of AI in medicine. His work has been featured in JAMA, NEJM AI, and The New York Times, and Dr. Crowe has spoken nationally and internationally on AI’s role in redesigning health systems.